TY  - RPRT
TI  - Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.
AU  - Lixin Guo
AU  - Xiaolei Bao
AU  - Kuo-Chin Huang
AU  - Kristoffer Jensen Kolnes
AU  - Christian Laugesen
AU  - Yibing Lu
AU  - Bifen Luo
AU  - Guoyue Yuan
AU  - Robert F Kushner
PY  - 2026
DO  - 10.1016/s2213-8587(26)00133-6
UR  - https://pubmed.ncbi.nlm.nih.gov/42575111/
ID  - 42575111
ER  -